0001493152-24-006050.txt : 20240213
0001493152-24-006050.hdr.sgml : 20240213
20240213150840
ACCESSION NUMBER: 0001493152-24-006050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240213
DATE AS OF CHANGE: 20240213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trenschel Robert J.
CENTRAL INDEX KEY: 0001849917
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33672
FILM NUMBER: 24625063
MAIL ADDRESS:
STREET 1: C/O SENECA BIOPHARMA, INC.
STREET 2: 20271 GOLDENROD LANE
CITY: GERMANTOWN
STATE: MD
ZIP: 20876
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PALISADE BIO, INC.
CENTRAL INDEX KEY: 0001357459
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 522007292
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7750 EL CAMINO REAL, SUITE 5200
CITY: CARLSBAD
STATE: CA
ZIP: 92009
BUSINESS PHONE: (858) 704-4900
MAIL ADDRESS:
STREET 1: 7750 EL CAMINO REAL, SUITE 5200
CITY: CARLSBAD
STATE: CA
ZIP: 92009
FORMER COMPANY:
FORMER CONFORMED NAME: Seneca Biopharma, Inc.
DATE OF NAME CHANGE: 20200127
FORMER COMPANY:
FORMER CONFORMED NAME: Neuralstem, Inc.
DATE OF NAME CHANGE: 20060324
4
1
ownership.xml
X0508
4
2024-02-08
1
0001357459
PALISADE BIO, INC.
PALI
0001849917
Trenschel Robert J.
7750 EL CAMINO REAL, SUITE 2A
CARLSBAD,
CA
92009
1
0
0
0
0
Common Stock, par value $0.01
2024-02-08
4
M
0
5100
0.00
A
5100
D
Common Stock, par value $0.01
2024-02-08
4
M
0
5820
0.00
A
10920
D
Restricted Stock Units
2024-02-08
4
M
0
5100
0.00
D
Common Stock
5100
0
D
Restricted Stock Units
2024-02-08
4
M
0
5820
0.00
D
Common Stock
5820
0
D
Common Stock Options
1.60
2024-02-08
4
M
0
12160
0.00
D
2023-06-11
2033-06-11
Common Stock
12160
0
D
Common Stock Options
1.60
2024-02-08
4
M
0
12160
0.00
A
2023-06-11
2033-06-11
Common Stock
12160
12160
D
Common Stock Options
0.59
2024-02-08
4
M
0
6880
0.00
D
2023-11-21
2033-11-21
Common Stock
6880
0
D
Common Stock Options
0.59
2024-02-08
4
M
0
6880
0.00
A
2023-11-21
2033-11-21
Common Stock
6880
6880
D
Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors.
This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding.
This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding.
Each restricted stock unit represents the right to receive one share of common stock.
Each option represents the right to purchase one share of common stock at the exercise price.
Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.
Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors.
/s/ Robert Trenschel
2024-02-13